NSE › Healthcare

Procter & Gamble Health Limited (PGHL)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹6,501.50-3.17%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹370 cr
Revenue YoY
+19.1%
Net profit
₹95 cr
Profit YoY
+54.6%
EPS
₹21.54
EPS estimate
₹30.90
Net margin
25.5%

EPS came in at 21.54 against a street estimate of 30.90 — a miss of 30.3%.

Key statistics

Market cap
₹11,145 cr
P/E
34.1
Forward P/E
0.0
P/B
21.25
Book value
₹316.00
EPS (TTM)
₹196.72
Dividend yield
2.31%
52-week high
₹6,975.00
52-week low
₹4,707.00
50-day MA
₹6,264.52
200-day MA
₹5,621.79
Beta
0.23

Analyst view

with an average price target of ₹7,535.00.

Shareholding

Promoters
52.20%
Institutions
16.45%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Procter & Gamble Health Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.